Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fellow’s Forum Case Report: Aneurysm in Takayasu’s Arteritis

G.C. Yathish, MD, Taral Parikh, MD, Parikshit Sagdeo, MD, Balakrishnan Canchi, MD, Gurmeet Mangat, MD, & Hemanth Kumar Pandharpurkar, MS  |  Issue: August 2015  |  August 17, 2015

PET-CT showing low to moderate inflammatory activity with aneurismal dilation of the left common femoral artery with thrombus.

Figure 2. PET-CT showing low to moderate inflammatory activity with aneurismal dilation of the left common femoral artery with thrombus.

In 2014, a repeat PET-CT showed low to moderate inflammatory activity with aneurysmal dilation of the left common femoral artery (see Figure 2). He was advised to have surgery for the aneurysm after a period of increased immunosuppression. Six months later, he underwent left common femoral artery and superficial femoral artery aneurysm excision, with external iliac artery to superficial femoral artery interposition grafting (see Figures 3 and 4). Histologically, the aneurysmal segment showed disorganization of the elastic lamina of the media, with inadequate supportive fibrous tissue, and a large intraluminal thrombus (see Figure 5).

Four months following the surgery, he is stable and able to resume his normal activities.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Key points of this presentation:

  • Although arterial narrowing is classical, aneurysms in TA are an important complication, and they can occur at multiple sites;
  • Patients need regular monitoring, even if they are asymptomatic, because aneurysms can progress despite normal values of inflammatory markers and PET-CTs showing low disease activity;
  • Rupture of these aneurysms can be catastrophic and, unlike atherosclerotic aneurysms, size may not be the only consideration for surgery;

    Table 2: Surgical Treatment in Takayasu’s Arteritis

    (click for larger image)
    Table 2: Surgical Treatment in Takayasu’s Arteritis

  • Timely surgical repair of aneurysms yields good results; and
  • Patient education regarding the continuation of medication and regular follow-up are very important.

Discussion

Takayasu’s arteritis (TA) is a large-vessel arteritis commonly described in young Asians. It involves the aorta and its branches, with stenosis more commonly seen than aneurysms. In a large number of patients, the disease progresses without any symptoms until critical ischemia results in symptoms of claudication. Any part of the aorta can be involved, and the most commonly affected branches are the subclavian and common carotid arteries.1,2 Stenotic lesions are found in >90% of patients, whereas aneurysms are reported in approximately 25%.2 Stenotic lesions and aneurysms are associated with considerable morbidity and mortality. The consequences of TA are often severe, with 74% of patients reporting considerably compromised daily activities and 23% of patients unable to work.2

Disease monitoring is a great challenge to the treating physician because there are no markers, which can reliably predict disease activity. Inflammatory markers are notoriously fallacious in assessing disease activity. High-resolution ultrasound (US), magnetic resonance angiography (MRA), CT angiography (CTA) and PET have been used for diagnosis and monitoring disease activity (see Table 1). However, there still is no consensus on which imaging modality should be routinely used.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:aneurysmsClinicalpatient carerheumatologistTakayasu’s Arteritis

Related Articles

    Fellow’s Forum Case Report: Takayasu’s Arteritis

    May 1, 2014

    How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

    Clues to Diagnosing, Managing Vanishing Aneurysms

    December 16, 2015

    Case report: A 27-year-old male was referred to the rheumatology outpatient department in February 2015 from the urology department after complaining of recent-onset uncontrolled hypertension (220/160 mmHg), headache and vomiting. In 2010, he was admitted to the urologist for sudden-onset left lumbar region pain and recent-onset hypertension. Clinical examination and the blood tests were normal….

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones

    January 23, 2019

    The FDA has granted priority review to a non-opioid, postoperative pain treatment, HTX-011…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences